Financhill
Back

I-MAB Stock Predictions

I-MAB Stock Forecast

  • Is I-MAB Stock Undervalued?
    The current I-MAB [IMAB] share price is $1.02. The Score for IMAB is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • IMAB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will I-MAB Stock Go Up Next Year?

Data Unavailable

I-MAB Stock Rating

Data Unavailable

I-MAB Stock Price History

Is IMAB stock going to rise?

  • The current trend is relatively stagnant and IMAB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
i-mabbiopharma.com

52-Week Data

52-Week High:
2.54
52-Week Low:
0.90

Prediction Charts

Market Cap:
83.13M
Price in USD:
1.02
Volume:
281.78K
Beta:
1.06

Technical Analysis

SMA50:
1.16
SMA100:
1.19
SMA200:
1.48
52-Wk Change:
-37.42%

Stock Predictions

  • Is I-MAB stock public?
    Yes, I-MAB is a publicly traded company.
  • What is the I-MAB stock quote today?
    The I-MAB stock price is 1.02 USD today.
  • How to buy I-MAB stock online?
    You can buy I-MAB shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-13 1.05 1.04 1.10 1.02
Nov-14 1.05 1.07 1.13 1.04
Nov-15 1.09 1.04 1.09 1.02
Nov-18 1.05 1.01 1.08 1.00
Nov-19 1.00 0.95 1.01 0.90
Nov-20 0.98 0.98 0.99 0.91
Nov-21 0.98 0.96 1.00 0.91
Nov-22 0.92 0.94 0.98 0.91
Nov-25 0.93 0.94 0.99 0.93
Nov-26 0.95 0.95 0.97 0.92
Nov-27 0.96 0.95 0.97 0.93
Nov-29 0.97 0.93 0.97 0.93
Dec-2 0.96 0.98 1.01 0.96
Dec-3 1.01 1.02 1.03 1.01

I-MAB Earnings

Data Unavailable

I-MAB Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.72 per share, and a decrease next year of $0.53 per share.

* I-MAB stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.